Sign In
Buy PRCT
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength?
05:16am, Wednesday, 10'th Jan 2024
PROCEPT BioRobotics Corporation (PRCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving high
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
05:00pm, Monday, 08'th Jan 2024
SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tran
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
04:03pm, Monday, 13'th Nov 2023
SAN JOSE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative
Wall Street Analysts Predict a 25.54% Upside in PROCEPT BioRobotics Corporation (PRCT): Here's What You Should Know
11:17am, Monday, 06'th Nov 2023
The mean of analysts' price targets for PROCEPT BioRobotics Corporation (PRCT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong
PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript
12:01am, Thursday, 02'nd Nov 2023
PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript
The 7 Best Tech Stocks To Buy Now: October 2023
01:37pm, Sunday, 22'nd Oct 2023
With the innovation sector moving at full speed, it's time for investors to consider the best tech stocks to buy now but not necessarily for the reason you might assume. Yes, the exchange-traded fund
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
04:05pm, Monday, 16'th Oct 2023
SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing tr
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
04:05pm, Thursday, 17'th Aug 2023
REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transforma
Procept BioRobotics: Adding Value Through Robust Unit Economics, Reiterate Buy
03:24pm, Thursday, 10'th Aug 2023
PRCT's aquablation therapy has shown strong growth, with revenues of $57.5mm in Q2 FY'23. The company's economic levers include new system placements, and growth from its installed base, with a record
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates
10:12am, Thursday, 27'th Jul 2023
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to loss of $0.43 per share a year ago.
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
04:03pm, Tuesday, 11'th Jul 2023
REDWOOD CITY, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developin
Procept BioRobotics: Adding For 2023 Rebound
10:19am, Tuesday, 30'th May 2023
Procept had weak results on adding fewer than expected Aquabeam devices in Q1 of 2023, leading to a fall in the shares. Procept has strong potential in urology where its Aquablation technology has man
7 Growth Stocks That Could Double Your Money in 2023
02:57pm, Sunday, 14'th May 2023
While the recent slow activity in the major indices clouds the narrative, you can still enjoy opportunities for growth stocks that could double your money. To be sure, you must be willing to accept so
PROCEPT BioRobotics Corporation (PRCT) Q1 2023 Earnings Call Transcript
09:31am, Sunday, 30'th Apr 2023
Start Time: 08:00 January 1, 0000 8:56 AM ET PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q1 2023 Earnings Conference Call April 27, 2023, 08:00 AM ET Company Participants Reza Zadno - President and
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
09:52am, Thursday, 27'th Apr 2023
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.39 per share a year ago.
